68
Participants
Start Date
November 24, 2020
Primary Completion Date
May 31, 2022
Study Completion Date
May 31, 2022
Gabapentin
600mg PO PO x 1 prior to surgery (in pre-op) 300mg PO BID for 7 days post op
Acetaminophen
Acetaminophen 1000mg PO x1 prior to surgery (in pre-op) Acetaminophen 1000mg PO q6h x 2 days then 1000mg q6h PRN post op
Celecoxib
Celecoxib 200mg PO q 12h x 7d post op
Ketorolac
30mg IV once at end of hysterectomy procedure
Paracervical block with ropivacaine
0.5% ropivacaine; 10 mL bilaterally (2 point) for total of 20mL
Local anesthetic injection with ropivacaine at abdominal laparoscopic port sites
0.5% ropivacaine; at all laparoscopic port sites; another 10mL ropivacaine in total
Hydromorphone
1mg IV PRN q3h, post op, while inpatient
Oxycodone
To be discharged home with: 12 tabs of 5mg PRN q4h
Millard Fillmore Suburban Hospital, Williamsville
State University of New York at Buffalo
OTHER